Startups
Caldera Therapeutics is a biotech company developing bispecific antibodies like CLD-423 for IBD and inflammatory diseases. Discover innovative autoimmune treatments today.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 16, 2026 | Amperon Secures Samsung Ventures Backing for Global AI Energy Forecasting Growth | Amperon, a leader in AI-powered energy forecasting, recently secured a significant investment from Samsung Venture Investment Corporation. This undisclosed funding fuels global expansion and advanced product development. Amperon’s AI soluti... |
| Jan 16, 2026 | Caldera Therapeutics Launches with $112.5M | CAMBRIDGE, MA, Caldera, a clinical stage biotechnology company, launched with $112.5 million total capital raised. >> Click here for more funding data on Caldera Therapeutics >> To export Caldera Therapeutics funding data to PD... |
| Jan 14, 2026 | Caldera Therapeutics Launches With $112.5 Million And Doses First Subjects In Phase 1 Trial Of CLD-423 | Caldera Therapeutics, a clinical-stage biotechnology company developing a first-in-class bispecific antibody for inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases, launched with $112.5 million in total capital... |
| Jan 14, 2026 | Caldera Therapeutics Launches with $112.5M in Total Capital | Caldera Therapeutics, Inc., a Cambridge, MA-based clinical stage biotechnology company, launched with $112.5M total capital raised. The amount consisted of a $75M Series A round from Atlas Venture, LAV and venBio, and most recently a $37.5M... |
| Jan 14, 2026 | Top Startup and Tech Funding News – January 14, 2025 | It’s Wednesday, January 14, 2026, and today’s funding landscape reflects growing confidence in AI-native robotics, security automation, and deep science ventures addressing energy and healthcare bottlenecks. From billion-dollar bets on gene... |
| Jan 14, 2026 | Amperon Receives Investment From Samsung Ventures | Amperon, a Houston, TX-based provider of AI-powered energy forecasting and analytics solutions, received an investment from Samsung Venture Investment Corporation. The amount of the deal was not disclosed. The company intends to use the fun... |
| Caldera Therapeutics | “Caldera Therapeutics is a biotech company developing bispecific antibodies like CLD-423 for IBD and inflammatory diseases. Discover innovative autoimmune treatments today.” |
Reviews 0
FAQ about Caldera Therapeutics
What has the press written about Caldera Therapeutics?
Parsers VC has collected 8 articles mentioning Caldera Therapeutics, among them “Amperon Secures Samsung Ventures Backing for Global AI Energy Forecasting Growth” (Jan 16, 2026) and “Caldera Therapeutics Launches with $112.5M” (Jan 16, 2026).
Is Caldera Therapeutics still active?
Caldera Therapeutics is probably closed: its latest activity on Parsers VC dates from Mar 30, 2026.